CompletedPhase 2

A Study of Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has Spread

NCT02102490

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Northern Arizona Hematology & Oncology Associates

Sedona, Arizona, United States

+35 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2014-06-10
Enrollment: 132 participants
Sponsor: Eli Lilly and Company
Purpose: treatment

Locations (36)

Northern Arizona Hematology & Oncology AssociatesSedona, Arizona, United States
HOPE Hematology Oncology Physicians and ExtendersTucson, Arizona, United States
Arizona Clinical Research CenterTucson, Arizona, United States
Univ of California San FranciscoSan Francisco, California, United States
Sansum Medical Research FoundationSanta Barbara, California, United States
Rocky Mountain Cancer CenterDenver, Colorado, United States
Washington Hospital CenterWashington D.C., District of Columbia, United States
Florida Cancer SpecialistsFort Myers, Florida, United States
Advanced Medical SpecialtiesMiami, Florida, United States
Florida Cancer SpecialistsSt. Petersburg, Florida, United States
Maryland Oncology Hematology, P.A.Columbia, Maryland, United States
Dana Farber Cancer InstituteBoston, Massachusetts, United States
Minnesota Oncology/Hematology PAMinneapolis, Minnesota, United States
Memorial Sloan Kettering Cancer CenterNew York, New York, United States
Oncology Hematology Care IncCincinnati, Ohio, United States
Sarah Cannon Research Institute SCRINashville, Tennessee, United States
Texas Oncology Cancer CenterAustin, Texas, United States
Texas Oncology - BedfordBedford, Texas, United States
Presbyterian Hospital DallasDallas, Texas, United States
Texas Oncology-Baylor Charles A. Sammons Cancer CenterDallas, Texas, United States
The Center for Cancer and Blood DisordersFort Worth, Texas, United States
Texas Oncology-Memorial CityHouston, Texas, United States
Texas Oncology-Plano WestPlano, Texas, United States
Texas Oncology-ShermanSherman, Texas, United States
US OncologyThe Woodlands, Texas, United States
Tyler Cancer CenterTyler, Texas, United States
Northwest Cancer Specialists PCVancouver, Washington, United States
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.Brussels, Belgium
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.Charleroi, Belgium
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.Leuven, Belgium
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.Liège, Belgium
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.Dijon, France
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.Paris, France
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.Barcelona, Spain
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.Madrid, Spain
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.Valencia, Spain